Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.

Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page
- Check6 days agoChange DetectedUpdated the page revision to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 has been added and the prior 3.4.1 notice has been removed.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added, stating information may not be up-to-date and that operations may be affected, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page adds a glossary toggle and new metadata headers such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with minor capitalization changes to labels like 'No FEAR Act Data'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the page. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.SummaryDifference0.1%

Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.